Company intelligence / Profile preview

Hublet

Ownership: Private
Development stage: Commercial

Overview

Hublet provides a cloud-based solution for managing and personalizing digital content on shared tablets. The system is used in public spaces such as libraries, hospitals, and educational institutions to streamline tablet lending and ensure secure, personalized access to digital resources. The platform includes features like remote device management, GDPR-compliant data privacy controls, customizable user profiles, and automated content delivery. It is recognized for its contribution to digital inclusivity but does not develop or market therapeutic products.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

No major pharmaceutical or biotech partnerships reported; some international distribution partners in technology/digital sectors

Beyond the preview

Go deeper on Hublet.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hublet.

Explore the full profile